<DOC>
	<DOCNO>NCT01112787</DOCNO>
	<brief_summary>The purpose study evaluate irritation level tazarotene foam 21 day exposure skin healthy volunteer .</brief_summary>
	<brief_title>A Study Evaluate Irritation Potential Tazarotene Foam Skin Healthy Volunteers</brief_title>
	<detailed_description>This Phase 1 , single center , evaluator-blinded , randomize , vehicle control study evaluate potential tazarotene foam induce cutaneous irritation use 21 day cumulative irritation assay healthy adult volunteer . Approximately 40 healthy male female volunteer subject age 18 65 year enrol . All subject expose patch contain tazarotene foam , vehicle foam , sodium lauryl sulfate 0.5 % ( positive control ) , distilled water ( negative control ) . Each set patch apply randomize site daily 21 day ; patch remove 24 Â±1 hour patch site evaluate sign inflammatory skin response ( eg , erythema , edema , papule ) superficial effect .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Tazarotene</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Capable understand willing provide sign dated write voluntary informed consent Health Information Portability Accountability Act ( HIPAA ) authorization protocolspecific procedure perform . Male female age 18 65 year , inclusive , time consent . Able willing complete study comply study instruction . Possess Fitzpatrick skin type I ( always burn easily ; never tan ) , II ( always burn easily ; tan minimally ) , III ( burn moderately ; tan gradually ) , IV ( rarely burn ; tan ease ) interfere evaluation skin response . Male subject partner must agree use medically acceptable method contraception . Additional criterion woman childbearing potential , define one biologically capable become pregnant , include perimenopausal woman le 2 year last menses : A regular menstrual cycle study entry ( report subject ) . Negative urine pregnancy test within 2 week first application study product . Sexually active female childbearing potential participating study must agree use medically acceptable method contraception throughout duration study . Women currently sexually active must agree use medically acceptable method contraception become sexually active participate study . Female pregnant , try become pregnant , breast feeding . Considered unable unlikely attend necessary visit . History know suspect intolerance tazarotene , ingredient study product , hypoallergenic tape , cotton patch . Participation patch test study within 4 week Day 1 visit . Inability evaluate skin around potential patch test sit back due sunburn , unevenness skin tone , tattoo , scar , excessive hair , freckle , birthmark , mole , skin damage abnormality . Clinically significant skin disease may contraindicate participation interfere patch test site evaluation , include psoriasis , eczema , atopic dermatitis , acne , dysplastic nevus , skin pathology , history skin cancer . Any major illness within 4 week Day 1 visit . Considered immunocompromised . A clinically relevant history current evidence abuse alcohol drug . Clinically relevant history currently suffer disease condition , opinion investigator , may affect evaluation study product place subject undue risk . This may include respiratory ( include chronic asthma require repetitive drug intervention ) , gastrointestinal , renal , hepatic , hematological , lymphatic , neurological , cardiovascular , psychiatric , musculoskeletal , genitourinary , immunological , dermatological , connective tissue diseases disorder . Received investigational product procedure within 4 week Day 1 visit schedule receive investigational product ( study product ) procedure study . Received allergy injection within 1 week Day 1 visit , expect receive allergy injection study participation . Received immunization within 4 week Day 1 visit . Used systemic topical corticosteroid immunosuppressive medication within 4 week Day 1 visit . Used topical medication product ( eg , self tan product , wax product , benzoyl peroxide , salicylic acid , sulfur ) area patch test within 2 week Day 1 visit . Used antihistamine , selective leukotriene receptor antagonist ( eg , montelukast sodium , zafirlukast ) , mast cell stabilizer ( eg , cromolyn sodium nedocromil sodium ) within 4 week Day 1 visit . Used nonsteroidal antiinflammatory medication within 2 week Day 1 visit . Currently use medication , opinion investigator , may affect evaluation study product place subject undue risk . Participated previous study study product . Employee study center , contract research organization , Stiefel involve study , immediate family member ( eg , partner , offspring , parent , sibling sibling 's offspring ) employee involve study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Healthy Volunteer Subjects</keyword>
</DOC>